A phase II study of capecitabine and docetaxel combination chemotherapy in patients with advanced gastric cancer
about
A dose escalation study of docetaxel plus capecitabine in combination with oxaliplatin in patients with advanced solid tumors.Paclitaxel combined with capecitabine as first-line chemotherapy for advanced or recurrent gastric cancer.Phase II study of weekly paclitaxel and capecitabine in patients with metastatic or recurrent esophageal squamous cell carcinoma.Capecitabine in gastric cancer.Elevated dietary linoleic acid increases gastric carcinoma cell invasion and metastasis in miceRecent advances in chemotherapy for advanced gastric cancerChemotherapy for advanced gastric cancer: across the years for a standard of care.Docetaxel and capecitabine for advanced gastric cancer: investigating dose-dependent efficacy in two patient cohorts.The role of thymidine phosphorylase, an angiogenic enzyme, in tumor progression.Clinical and experimental study of oxaliplatin in treating human gastric carcinomaRecent developments in chemotherapy of advanced gastric cancer.Recent developments in the systemic therapy of advanced gastroesophageal malignancies.Comparison of efficacy of different route of administration of chemotherapy on unresectable, advanced gastric cancerPolymorphisms of glutathione S-transferases (GST) and thymidylate synthase (TS)--novel predictors for response and survival in gastric cancer patientsA phase II study of capecitabine plus 3-weekly oxaliplatin as first-line therapy for patients with advanced gastric cancer.Phase II study of capecitabine and irinotecan combination chemotherapy in patients with advanced gastric cancer.Phase I/II study of docetaxel and S-1 in patients with advanced gastric cancer.A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancer.Phase I/II study of S-1 combined with weekly docetaxel in patients with metastatic gastric carcinoma.Randomised phase II evaluation of irinotecan plus high-dose 5-fluorouracil and leucovorin (ILF) vs 5-fluorouracil, leucovorin, and etoposide (ELF) in untreated metastatic gastric cancer.Docetaxel in the treatment of gastric cancer.Recent advances in the treatment of peritoneal dissemination of gastrointestinal cancers by nucleoside antimetabolites.Capecitabine in advanced gastric cancer.Dual Drug Loaded Biodegradable Nanofibrous Microsphere for Improving Anti-Colon Cancer Activity.Current approaches to gastric cancer in Korea.Capecitabine in the treatment of advanced gastric cancer.Phase II study of neo-adjuvant chemotherapy for locally advanced gastric cancer.Emerging role of capecitabine in gastric cancer.Chemotherapy for advanced gastric cancer: slow but further progress.Evaluation of Outcome and Tolerability of Combination Chemotherapy with Capecitabine and Oxaliplatin as First Line Therapy in Advanced Gastric Cancer.Role of capecitabine and irinotecan combination therapy in advanced or metastatic gastric cancer.Capecitabine for the treatment of gastric cancer.Perioperative chemotherapy with docetaxel, cisplatin and capecitabine (DCX) in gastro-oesophageal adenocarcinoma: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO){dagger}.Preoperative chemotherapy with cisplatin and docetaxel followed by surgery and clip-oriented postoperative chemoradiation in patients with localized gastric or gastroesophageal junction adenocarcinoma: results from a phase II feasibility study.Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer.Phase II study of docetaxel and capecitabine in patients with metastatic or recurrent gastric cancer.Long Term Complete Remission in Advanced Gastric Adenocarcinoma With Docetaxel, Oxaliplatin and Capecitabine Combination Regimen.A multicenter, randomized trial comparing efficacy and safety of paclitaxel/capecitabine and cisplatin/capecitabine in advanced gastric cancer.
P2860
Q33386694-80967F9C-A4AD-44D0-B18F-7C331B85ADA6Q33778285-85B428D3-DE8C-4EED-B17B-0A7355591985Q34010159-053E86EB-7750-4670-91B0-D5E5AE96CEA3Q34236005-D8991611-F791-4851-84FD-04A4EC5D3244Q34255969-3C9296DF-6236-4B04-999C-6FCFF46352C8Q34389753-B89ADEF5-F676-4A94-BC37-1AA58285442AQ34617795-1272F582-F53D-4A4D-8BEB-157E07D8BC5AQ35208094-6E222083-91F7-4D93-B951-DAD09E391F92Q35951880-69C0AAF3-659C-41E6-9031-701590B02A83Q36065649-A9DE0A3B-157D-4C11-B7C3-E7176D5C23DBQ36090047-256073D0-18E0-43C0-94CB-5A5A816A3845Q36376439-EA0E575B-E358-4BA2-845B-758FA8FA4C79Q36402491-CFDC71C9-23F0-4D0C-8C67-8AB4B8AC3208Q36613622-CA49246A-8A69-48C0-B9DD-AC94805F3E1BQ36614036-8665B75A-90F6-4166-9509-B28BAEDC020EQ36614248-96C1931C-DFDF-49FD-A059-DF02BECF7D94Q36614394-B2AA671D-0FD3-4223-BB4A-D884055EDD86Q36614734-BD865447-7AA4-4550-AA09-61424C1AB22CQ36615597-BFF825FD-5B58-4ABF-8374-614DA6018AB9Q36616011-DB062A4D-AD5C-4497-8B24-3BB08C505B32Q36616503-A2B39D5F-D0B3-4208-92BF-BF946FE84FB3Q36628679-4DC5EFD2-C7A9-41EB-843C-41327CA1E002Q36979346-B6144741-11AA-4F95-8F4B-10FBEBD1F557Q37023985-A9B5B56B-ECCA-4125-B1B9-781224ED3F05Q37077836-CA73FDA1-FB99-411E-B856-98C34996C614Q37136996-2D0FBE4C-78B7-497B-ABA4-B672F18B0E8FQ37236380-507DF8DC-C91D-44BD-A9D9-99DF206E2391Q37403462-B86C7884-5AB7-46CE-A49E-0B563D2FF893Q37446941-42D3B787-7B97-437D-B2D9-2E4895748681Q37477979-50C2CD1A-7E8D-4855-80E8-ABB189343476Q37732285-DB1E95A1-B02D-4218-A4B4-EB90ABD65684Q38608072-3F4470FD-96EC-44D5-9B36-D82E9E5E8689Q40282337-CC26FBE5-E908-41BD-911E-3D872BA6D5D6Q40343915-69422E75-EE9C-4A46-8F9E-3E25337B4156Q40349569-EE52C4B6-5512-4546-A54F-4B2123B7AF72Q46592440-E83F77C2-E5CA-415B-B5A1-7E9B2DD60435Q47168501-DA7E411B-9651-4D66-9E01-489DEBA66BBBQ52682114-D6CA6C7A-2DF7-42A1-9469-92D4EB8B8E33
P2860
A phase II study of capecitabine and docetaxel combination chemotherapy in patients with advanced gastric cancer
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
A phase II study of capecitabi ...... s with advanced gastric cancer
@ast
A phase II study of capecitabi ...... s with advanced gastric cancer
@en
type
label
A phase II study of capecitabi ...... s with advanced gastric cancer
@ast
A phase II study of capecitabi ...... s with advanced gastric cancer
@en
prefLabel
A phase II study of capecitabi ...... s with advanced gastric cancer
@ast
A phase II study of capecitabi ...... s with advanced gastric cancer
@en
P2093
P2860
P356
P1476
A phase II study of capecitabi ...... s with advanced gastric cancer
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6601724
P407
P577
2004-04-01T00:00:00Z